Trademark Attorney / Law Firm
Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald – Trademark Portfolio
Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 1 total filing concentrated in this category. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald's trademark practice covers 1 Nice Classification class, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald filed?
Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald has filed 1 trademark application with the United States Patent and Trademark Office (USPTO).
What trademark classes does Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald specialize in?
Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald has filed trademarks across 1 Nice Classification class. The most common practice areas include Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald's trademark registration success rate?
Michael Fletcher, James Wolfson, Gail Podolsky, Nancy Flint, William Giltinan, C. Douglas McDonald has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.